in Spain, its current prevalence ranges between 2833%11,12 and it is a recognized as a cardiovascular risk factor and increases the mortality in this population.1315 Furthermore, in patients with DM2 and advanced CKD there are limitations in the prescription of certain antihyperglycemic drugs (e.g., metformin or sulfonylureas) and there is an increased risk of hypoglycemia with antihyperglycemic treatment,16 a complication that is associated with increased cardiovascular risk17 and hinders the achievement of glycemic control targets
With this new approval, patients now have a more convenient, needle-free option that may make it easier to start or stick with treatment
The fractions of from 10-15 as indicated were combined as 1P Main Fraction for the subsequent second purification
For example, if the dose is too low, unresolved symptoms of hypothyroidism such as weight gain may persist, explains Dr
Br J Nutr 2011;105(8):1210-1217
Availability of data and materials The data used in the observational study are available from the corresponding author upon reasonable request